Protective effects of the free radical scavenger edaravone against glutamate neurotoxicity in nearly pure neuronal culture.
OBJECTIVE
Edaravone, a free radical scavenger, has shown neuroprotection in both animals and humans. To evaluate the mechanism of this protection, we examined the effect of edaravone on neurons themselves against glutamate neurotoxicity.


METHODS
Neurons were collected from 18-day fetal rat brains and a culture of almost pure neurons was obtained after 14-day culture. The neurons were exposed to 50 muM glutamate for 10 min, followed by normal culture for 24 h. Edaravone was added to the medium during the glutamate insult (prophylactic effect) or after the insult (treatment effect). First, the cell survival rate was measured by staining with trypan blue. Second, the cells were stained with 6-carboxy-2', 7'-dichlorodihydrofluorescein diacetate, di-(acetoxymethyl ester) (C-DCDHF-DA) and the relative amount of reactive oxygen species (ROS) was measured by flow cytometry. Third, the cells were stained with Hoechst 33342 and propidium iodide and the numbers of apoptotic and necrotic cells were counted.


RESULTS
A dose-dependent prophylactic effect was observed and the cell survival rate in 500 muM edaravone was significantly higher than that without it. However, there was no treatment effect beyond 2 h after the insult. The amount of ROS under 500 muM edaravone at 4 h after the glutamate insult was significantly lower than the control amount. Necrosis, but not apoptosis, was significantly inhibited by edaravone.


CONCLUSIONS
Edaravone mainly showed a prophylactic effect on neurons against glutamate neurotoxicity, possibly through the inhibition of necrosis via the suppression of ROS production. However, for a protective effect, a higher, supraclinical concentration was required, compared to the concentrations producing a protective effect in glial and endothelial cells in previous studies.
Hisano
Kenjiro
K
Department of Anesthesiology and Critical Care Medicine, Hokkaido University Graduate School of Medicine, N15 W7, Kita-ku, Sapporo 060-8638, Japan.
Watanabe
Masahiko
M
Morimoto
Yuji
Y
D000818:Animals; D000983:Antipyrine / Q000031:analogs & derivatives* / Q000494:pharmacology; D017209:Apoptosis / Q000187:drug effects; D002470:Cell Survival / Q000187:drug effects; D002478:Cells, Cultured; D004305:Dose-Response Relationship, Drug; D000077553:Edaravone; D018691:Excitatory Amino Acid Antagonists; D005456:Fluorescent Dyes; D016166:Free Radical Scavengers / Q000494:pharmacology*; D018698:Glutamic Acid / Q000633:toxicity*; D009336:Necrosis; D009457:Neuroglia / Q000187:drug effects / Q000473:pathology; D009474:Neurons / Q000187:drug effects* / Q000473:pathology; D018696:Neuroprotective Agents; D051381:Rats; D017208:Rats, Wistar; D017382:Reactive Oxygen Species / Q000378:metabolism
D018691:Excitatory Amino Acid Antagonists; D005456:Fluorescent Dyes; D016166:Free Radical Scavengers; D018696:Neuroprotective Agents; D017382:Reactive Oxygen Species; D018698:Glutamic Acid; D000077553:Edaravone; D000983:Antipyrine
Stroke. 2005 Oct;36(10):2220-5
16166574
J Neurosci. 1987 Feb;7(2):357-68
2880937
J Neurol Sci. 2003 Nov 15;215(1-2):31-6
14568125
J Biol Chem. 2000 Nov 24;275(47):37159-66
10980192
Curr Mol Med. 2004 Mar;4(2):149-77
15032711
J Neurochem. 2005 Oct;95(1):179-90
16181422
Neuropharmacology. 2005 Feb;48(2):283-90
15695167
Neurol Med Chir (Tokyo). 2005 Jul;45(7):344-8; discussion 348
16041179
J Neurol Sci. 2004 Jun 15;221(1-2):11-7
15178207
J Pharmacol Exp Ther. 1997 May;281(2):921-7
9152402
J Neurochem. 2006 Jun;97(5):1431-46
16606357
Cancer Res. 1996 May 1;56(9):2161-6
8616866
Surg Neurol. 2005 Oct;64(4):309-13; discussion 313-4
16182000
J Neurol Sci. 2000 Mar 1;174(1):9-15
10704975
J Anesth. 2007;21(3):367-77
17680190
J Anesth. 2005;19(2):150-6
15875133
Biochim Biophys Acta. 1997 Mar 10;1345(1):35-42
9084499
Clin Hemorheol Microcirc. 2006;34(1-2):163-8
16543632
Free Radic Biol Med. 2000 Mar 1;28(5):665-72
10754261
Annu Rev Neurosci. 1990;13:171-82
1970230
Acta Pharmacol Sin. 2007 Nov;28(11):1724-30
17959022
Brain Res. 1997 Jul 11;762(1-2):240-2
9262182
J Neurochem. 1998 Sep;71(3):1177-86
9721743
J Zhejiang Univ Sci B. 2006 Sep;7(9):749-56
16909478
J Neurochem. 1998 Jan;70(1):316-24
9422377
J Neurochem. 2005 Feb;92(3):692-700
15659238
Brain Res Dev Brain Res. 2004 Jul 19;151(1-2):129-39
15246699
Biol Pharm Bull. 2006 Aug;29(8):1613-7
16880614
Acta Neurochir Suppl. 2003;86:199-203
14753435
Eur J Neurosci. 2004 Dec;20(11):2929-44
15579147
Cerebrovasc Dis. 2003;15(3):222-9
12715790
Brain Res. 2004 Dec 17;1029(2):200-6
15542075
J Neurosci. 2001 Oct 1;21(19):7691-704
11567059